Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Gilat Satellite Networks Ltd. reported robust second quarter 2026 financial results with revenues increasing 17% to $122.7 million and adjusted EBITDA growing 31% to $15.4 million. The company reiterated its 2026 financial guidance projecting continued revenue and EBITDA growth. Progress on the acquisition of Comtech's Satellite & Space Communicati…
Lifecore Biomedical reported its Q2 2026 financial results, showing a slight revenue decrease compared to prior year periods. The company added multiple new late-stage programs to its pipeline, emphasized ongoing cost reduction and productivity improvements, and reaffirmed full-year 2026 revenue and Adjusted EBITDA guidance. Despite current losses,…
Dynatrace shares climbed sharply in pre-market trading after the company released first quarter fiscal 2027 results ahead of the U.S. open, with both adjusted earnings per share and revenue materially surpassing analyst forecasts. The surprise beat, coupled with recent price-target increases from analysts and fresh enhancements to the companys Dyna…
Prudential PLC shares fell sharply, sliding 11.7% to 967p and hitting an intraday low of 950.8p after a report said China is broadening tax enforcement to include offshore insurance policies. The potential effect on affluent Chinese buyers, an important source of sales in Hong Kong, intensified selling pressure despite continued analyst support, an…
UBS published a quantitative review of crowded positioning in the consumer staples sector for July 2026, listing the stocks most widely held on the long side and those most heavily shorted by eligible funds. The bank stresses that concentration alone is not a forecast of future returns and applies a proprietary "Crowding Momentum" score to detect e…
Reddit reported 61% revenue growth and $253M in net income but saw a small sequential decline in U.S. daily users that sparked a sharp 21% correction. Fundamentals remain solid: $805M in revenue for the quarter, $1.02B in free cash flow trailing, roughly $4.4B of cash and no recorded debt. This trade idea targets a bounce back to $195 from a $161 e…
Fennec Pharmaceuticals, a specialty pharmaceutical company focused on reducing ototoxicity in cancer patients treated with cisplatin chemotherapy, will release its second quarter 2026 financial results on August 11, 2026, before U.S. market open. The company will host a conference call and webcast to discuss results. Fennec commercializes PEDMARK®,…
CLPBF has cleared several key moving averages, shows bullish MACD momentum and sits under intense short interest amid very low average daily volumes. That combination creates a tactical trade opportunity: enter a measured long near $66.00 with a tight stop and a near-term target at $75.00, while sizing for illiquidity and the possibility of volatil…
Amprius Technologies saw a significant pre-market share gain after reporting second-quarter 2026 revenue that more than doubled year-over-year and beating Street expectations, while management raised its 2026 revenue guidance and reiterated profitability targets. A GAAP EPS miss reflected a non-cash warrant modification; excluding that item the qua…
Several of Asia's largest multi-strategy hedge funds logged their biggest monthly drawdowns of the year in July as a severe selloff in semiconductor and AI-related equities erased gains accumulated earlier in 2024. While multi-strategy platforms generally outperformed the region's broader stock-picking hedge fund cohort, losses in July were nonethe…
Lexeo Therapeutics has received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for LX2020, its investigational gene therapy targeting PKP2-associated arrhythmogenic cardiomyopathy. This designation, along with prior Orphan Drug and Fast Track statuses, highlights promising interim clinical data from the ongoing Phase I/II HEROIC-PKP2…
Advantage Solutions Inc. reported Q2 2026 revenues of $889.5 million, a 1.8% increase year-over-year, driven primarily by growth in Experiential Services and slight growth in Retailer Services while Branded Services declined. Despite higher revenue, net loss widened to $62.7 million and Adjusted EBITDA dropped 12.2% to $75.8 million. The company re…
TeraWulf reported second quarter 2026 results highlighting revenue growth with 102 MW of revenue-generating capacity at Lake Mariner and 336 MW under construction. The company secured a landmark 20-year, approximately $19 billion lease with Anthropic at its Kentucky Justified Data Campus and acquired the gigawatt-scale Muskie Data Campus. TeraWulf …
Astec Industries, Inc. reported its second quarter 2026 financial results with net sales rising 23.6% to $408.1 million and backlog increasing nearly 58%. Despite growth in Materials Solutions, delays in Infrastructure Solutions asphalt plant shipments caused a reduction in full-year adjusted EBITDA guidance from $170-$190 million to $160-$175 mill…
Atea Pharmaceuticals, a late-stage biopharmaceutical company developing oral antivirals for serious viral diseases, announced its Q2 2026 financial results call scheduled for August 12, 2026. The company continues to progress its Phase 3 hepatitis C program and Phase 1 hepatitis E study, sharing updates with investors.
Telix Pharmaceuticals Limited will host an R&D Day event in New York City on September 22, 2026, providing investors and analysts with a comprehensive update on its therapeutic and precision medicine pipeline. The event will feature presentations from company leadership and key opinion leaders, highlighting clinical, scientific, and strategic devel…
Hennessy Capital Investment Corp. VII (NASDAQ: HVII) and ONE Nuclear Energy LLC announced that the SEC has declared effective their registration statement, enabling a shareholder meeting on August 24, 2026, to approve their proposed business combination. Upon closing, ONE Nuclear Energy Inc. will become a publicly traded company on NASDAQ under the…
J & J Snack Foods Corp. reported its fiscal 2026 third quarter results with a 6.2% decline in net sales to $426 million, impacted mainly by reduced bakery and frozen beverage machine sales. Despite lower sales, gross profit rose slightly and gross margin expanded by 240 basis points to 35.5%, attributed to operational efficiencies under the Apollo …
Royalty Pharma plc announced robust second quarter 2026 results with 14% growth in Royalty Receipts to $768 million and an overall 6% increase in Portfolio Receipts to $773 million. The company raised its full-year 2026 portfolio receipts guidance to $3.4 to $3.5 billion driven by strong performance of key products and active investments in new roy…
Kaltura, Inc. announced strong second quarter 2026 results, surpassing revenue and adjusted EBITDA guidance. Subscription revenue grew 8% year-over-year to $45.6 million, with total revenue at $46.9 million. The company achieved record non-GAAP gross margin of 75% and its highest Q2 adjusted EBITDA to date at $5.9 million. Kaltura signed a record f…
Climb Global Solutions, Inc., a U.S.-based technology distributor, announced a distribution partnership with Harmonic Security to offer its AI governance platform to value-added resellers and managed service providers. This collaboration targets enhanced security for mid-market and enterprise adoption of AI, addressing risks from autonomous AI agen…
VisionWave Holdings, Inc. announced a planned acquisition of at least 51% of D-Fence Electronic Fencing Systems Ltd., an Israeli developer of AI-driven perimeter security technologies used in critical infrastructure worldwide. The transaction aims to build a comprehensive AI-powered defense platform by integrating D-Fence's solutions with VisionWav…
NewAmsterdam Pharma reported positive regulatory milestones, including a favorable CHMP opinion recommending marketing authorization for obicetrapib and its fixed-dose combination with ezetimibe in Europe. The company provided updates on ongoing Phase 3 cardiovascular and Alzheimer's disease trials, announced cash position of $678.3 million as of J…
BioCryst Pharmaceuticals reported robust Q2 2026 financial results with total net revenue of $218.3 million, an operating profit of $98.5 million, and maintained full-year ORLADEYO revenue guidance while raising total revenue outlook. Key milestones include starting shipments of ORLADEYO oral pellets for pediatric hereditary angioedema patients and…
Ascent Solar Technologies highlights its growing involvement in the expanding drone market alongside its core space industry applications. The company secured orders from satellite manufacturers and unmanned aerial and marine vehicle producers, showcasing its innovative thin-film photovoltaic technology that offers a superior power-to-weight ratio.…
